Fosamax

Recent studies have linked the prescription drug Fosamax to a severe and debilitating condition known as osteonecrosis. This ailment is implicated with the restriction of blood supply to the bone and the damage that occurs as a consequence. The lawyers at Carey & Danis have represented individuals nationwide who have been hurt as a result of taking this Fosamax.

Serious necrosis of the jaw and other bone death have been associated with Fosamax, manufactured by Merck. Bone death, or necrosis, is also known as osteonecrosis. Fosamax has particularly been associated with osteonecrosis of the jaw, or ONJ. The lawyers at Carey & Danis have experience in this litigation and have assisted victims of Fosamax nationwide

In August of 2004, the FDA asked Merck to update its warning on Fosamax to include the risk of osteonecrosis of the jaw, Merck has you to comply.

Almost 10 million people take Fosamax.

If you or anyone you know has experienced osteonecrosis of the jaw, or ONJ, as a result of taking Fosamax, please contact one of the experienced pharmaceutical liability attorneys at Carey & Danis immediately to discuss your case.